Analysis fuels debate on statins for low risk people

摘要

The controversy concerning the prescribing of statins to more people showed no signs of abating this week after a new analysis—this time of high quality observational studies involving data on millions of patients—found that the risk of harmful effects from statins was very small and similar to those seen in clinical trials.The finding is fuelling the debate on whether statins should be extended to healthy people who are at low risk of cardiovascular disease, as recommended in draft guidance from the National Institute for Health and Care Excellence (NICE).